InvestorsHub Logo
Followers 37
Posts 7164
Boards Moderated 1
Alias Born 09/06/2014

Re: Probity post# 330127

Thursday, 06/13/2024 8:38:07 AM

Thursday, June 13, 2024 8:38:07 AM

Post# of 331794
I'm not trying to trash or invalidate that study or its authors.

I'm saying that from a scientific standpoint, the evidence for a reduction in opioid use in that study is not going to convince the CMS to approve RecoveryRx for reimbursement under the NOPAIN Act.

For the reasons I stated.

I guess we'll have to wait for 2025 to see if I'm right.